BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10442449)

  • 1. Expression of costimulatory molecules on peripheral blood mononuclear cells in multiple sclerosis.
    Mena E; Rohowsky-Kochan C
    Acta Neurol Scand; 1999 Aug; 100(2):92-6. PubMed ID: 10442449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the costimulator molecules, CD80, CD86, CD28, and CD152 on lymphocytes from neonates and young children.
    Elliott SR; Macardle PJ; Roberton DM; Zola H
    Hum Immunol; 1999 Nov; 60(11):1039-48. PubMed ID: 10600000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis.
    Melichar B; Nash MA; Lenzi R; Platsoucas CD; Freedman RS
    Clin Exp Immunol; 2000 Jan; 119(1):19-27. PubMed ID: 10606960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of costimulatory molecules in chronic inflammatory periodontal disease tissue.
    Orima K; Yamazaki K; Aoyagi T; Hara K
    Clin Exp Immunol; 1999 Jan; 115(1):153-60. PubMed ID: 9933436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costimulatory molecules in Wegener's granulomatosis (WG): lack of expression of CD28 and preferential up-regulation of its ligands B7-1 (CD80) and B7-2 (CD86) on T cells.
    Moosig F; Csernok E; Wang G; Gross WL
    Clin Exp Immunol; 1998 Oct; 114(1):113-8. PubMed ID: 9764612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD80 and CD86 costimulatory molecules on circulating T cells of HIV infected individuals.
    Köchli C; Wendland T; Frutig K; Grunow R; Merlin S; Pichler WJ
    Immunol Lett; 1999 Feb; 65(3):197-201. PubMed ID: 10065743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of costimulatory molecules (CD28-CTLA-4/B7) expression on chosen mononuclear cells in adolescents with Graves' disease during methimazole therapy].
    Bossowski A; Stasiak-Barmuta A; Urban M; Rinderle C
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(2):93-101. PubMed ID: 15504312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic analysis of lymphocytes and monocytes/macrophages in peripheral blood and bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis.
    Wahlström J; Berlin M; Sköld CM; Wigzell H; Eklund A; Grunewald J
    Thorax; 1999 Apr; 54(4):339-46. PubMed ID: 10092696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced expression of CTLA-4 (CD152) on CD4+ T cells in HIV infection.
    Steiner K; Waase I; Rau T; Dietrich M; Fleischer B; Bröker BM
    Clin Exp Immunol; 1999 Mar; 115(3):451-7. PubMed ID: 10193417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD80 expression is induced on activated B cells following stimulation by CD86.
    Sahoo NC; Rao KV; Natarajan K
    Scand J Immunol; 2002 Jun; 55(6):577-84. PubMed ID: 12028560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of short-term protein malnutrition of mice on the phenotype and costimulatory signals of lymphocytes from spleen and Peyer's patches.
    Manhart N; Vierlinger K; Bergmeister H; Boltz-Nitulescu G; Spittler A; Roth E
    Nutrition; 2000 Mar; 16(3):197-201. PubMed ID: 10705075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of human inducible costimulator ligand expression and function.
    Aicher A; Hayden-Ledbetter M; Brady WA; Pezzutto A; Richter G; Magaletti D; Buckwalter S; Ledbetter JA; Clark EA
    J Immunol; 2000 May; 164(9):4689-96. PubMed ID: 10779774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low CD86 expression in the nonobese diabetic mouse results in the impairment of both T cell activation and CTLA-4 up-regulation.
    Dahlén E; Hedlund G; Dawe K
    J Immunol; 2000 Mar; 164(5):2444-56. PubMed ID: 10679081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costimulatory molecules in human periodontal disease tissues.
    Gemmell E; McHugh GB; Grieco DA; Seymour GJ
    J Periodontal Res; 2001 Apr; 36(2):92-100. PubMed ID: 11327084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and functional role of co-stimulatory molecules in CD40+IL-4-stimulated B cells from atopic and non-atopic donors.
    Oberwalleney G; Henz BM; Worm M
    Acta Derm Venereol; 2000; 80(4):287-91. PubMed ID: 11028864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of T and B cell responses by modulating interactions between CD28/CTLA4 and their ligands, CD80 and CD86.
    Lane P
    Ann N Y Acad Sci; 1997 Apr; 815():392-400. PubMed ID: 9186685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of B7 costimulation in CD4/CD8 T cell homeostasis.
    Yu X; Fournier S; Allison JP; Sharpe AH; Hodes RJ
    J Immunol; 2000 Apr; 164(7):3543-53. PubMed ID: 10725709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costimulation light: activation of CD4+ T cells with CD80 or CD86 rather than anti-CD28 leads to a Th2 cytokine profile.
    Broeren CP; Gray GS; Carreno BM; June CH
    J Immunol; 2000 Dec; 165(12):6908-14. PubMed ID: 11120816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization in situ of costimulatory molecules and cytokines in B-cell non-Hodgkin's lymphoma.
    Vyth-Dreese FA; Boot H; Dellemijn TA; Majoor DM; Oomen LC; Laman JD; Van Meurs M; De Weger RA; De Jong D
    Immunology; 1998 Aug; 94(4):580-6. PubMed ID: 9767448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of CTLA-4 (CD152) with CD80 or CD86 inhibits human T-cell activation.
    Vandenborre K; Van Gool SW; Kasran A; Ceuppens JL; Boogaerts MA; Vandenberghe P
    Immunology; 1999 Nov; 98(3):413-21. PubMed ID: 10583602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.